NCT07304154 2026-03-10A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic DiseasesGilead SciencesPhase 1 Not yet recruiting52 enrolled
NCT06220201 2026-02-10A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyPhase 1 Recruiting120 enrolled